Cadrenal Therapeutics Inc (CVKD)’s price-to-cash and price-to-free cash flow ratios

The price of Cadrenal Therapeutics Inc (NASDAQ: CVKD) closed at $1.82 in the last session, up 8.33% from day before closing price of $1.68. In other words, the price has increased by $+0.1400 from its previous closing price. On the day, 762184 shares were traded. CVKD stock price reached its highest trading level at $1.8500 during the session, while it also had its lowest trading level at $1.6100.

#1 Small-Cap Uranium Stock for Ultra-Fast Gains in 2024

We've uncovered THE ONE small-cap uranium stock that has unearthed a near-surface, high-grade uranium discovery in the Saudi Arabia of Uranium — Canada's prolific Athabasca Basin. Best of all, this small-cap uranium stock is currently flying just below Wall Street's radar… giving you the early-entry opportunity around US$0.30 per share. But that won't last long. Drills are turning right now with results set to be released to the market very, very soon.

Learn all about it in this brand new FREE online report.


We take a closer look at CVKD’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 16.46 and its Current Ratio is at 16.46. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Noble Capital Markets on December 18, 2023, initiated with a Outperform rating and assigned the stock a target price of $4.

Insider Transactions:

An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Oct 05 when MURPHY JOHN RAYMOND bought 2,669 shares for $0.69 per share. The transaction valued at 1,842 led to the insider holds 614,792 shares of the business.

MURPHY JOHN RAYMOND bought 17,331 shares of CVKD for $12,132 on Oct 04. The Director now owns 612,123 shares after completing the transaction at $0.70 per share. On Sep 05, another insider, Pham Quang X, who serves as the CEO and Chairman of the company, bought 40,000 shares for $0.90 each. As a result, the insider paid 36,188 and bolstered with 3,410,000 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CVKD now has a Market Capitalization of 23.69M and an Enterprise Value of 14.61M.

Stock Price History:

Over the past 52 weeks, CVKD has reached a high of $3.16, while it has fallen to a 52-week low of $0.40. The 50-Day Moving Average of the stock is 0.6896, while the 200-Day Moving Average is calculated to be 0.9568.

Shares Statistics:

According to the various share statistics, CVKD traded on average about 197.34K shares per day over the past 3-months and 743.38k shares per day over the past 10 days. A total of 11.63M shares are outstanding, with a floating share count of 5.45M. Insiders hold about 58.17% of the company’s shares, while institutions hold 8.49% stake in the company. Shares short for CVKD as of Jan 11, 2024 were 40.21k with a Short Ratio of 0.04M, compared to 50.91k on Dec 14, 2023. Therefore, it implies a Short% of Shares Outstanding of 0.31% and a Short% of Float of 0.73%.

Earnings Estimates

The company has Cadrenal Therapeutics, Inc. analysts who recommend its stock at the moment.

Leave a Reply

Your email address will not be published. Required fields are marked *

Most Popular